Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin

<p>Abstract</p> <p>Background</p> <p>In this paper, we report the health related quality of life (HRQOL) data from patients with hepatitis C viral infection (HCV) who were refractory to prior therapy and had re-treatment with a combination of Pegylated interferon alpha-...

Full description

Bibliographic Details
Main Authors: McGarrity Thomas J, Rhoades Kathy, Peiffer Laurie P, Mathew Abraham
Format: Article
Language:English
Published: BMC 2006-05-01
Series:Health and Quality of Life Outcomes
Online Access:http://www.hqlo.com/content/4/1/30